Fox C K, Kaizer A M, Ryder J R, Rudser K D, Kelly A S, Kumar S, Gross A C
Department of Pediatrics University of Minnesota Minneapolis USA.
Department of Biostatistics University of Minnesota Minneapolis USA.
Obes Sci Pract. 2018 Apr 10;4(3):207-215. doi: 10.1002/osp4.166. eCollection 2018 Jun.
Although obesity affects approximately one in five youths, only a fraction is treated in pediatric weight management clinics. Characteristics distinguishing youth with obesity who seek weight management treatment from those who do not are largely unknown. Yet identification of specific health characteristics which differentiate treatment-seeking from non-treatment seeking youth with obesity may shed light on underlying motivations for pursuing treatment.
Compare the cardiometabolic profiles of an obesity treatment-seeking sample of youth to a population-based sample of youth with obesity, while controlling for body mass index (BMI).
This cross-sectional study included participants, ages 12-17 years, with obesity from the Pediatric Obesity and Weight Evaluation Registry (POWER) and National Health and Nutrition Examination Survey, representing the treatment-seeking and population samples, respectively. Mean differences were calculated for systolic and diastolic blood pressure percentiles, total cholesterol, low-density and high-density lipoprotein-cholesterol, triglycerides, fasting glucose, glycated hemoglobin and alanine aminotransferase, while adjusting for age, sex, race/ethnicity, insurance status, and multiple of the 95th BMI percentile.
The POWER and National Health and Nutrition Examination Survey cohorts included 1,823 and 617 participants, respectively. The POWER cohort had higher systolic blood pressure percentile (mean difference 17.4, 95% confidence interval [14.6, 20.1], p < 0.001), diastolic blood pressure percentile (21.8 [19, 24.5], p < 0.001), triglycerides (42.3 [28, 56.5], p < 0.001) and alanine aminotransferase (7.5 [5.1, 9.8], p < 0.001) and lower fasting glucose (-6.9 [-8.2, -5.6], p < 0.001) and high-density lipoprotein-cholesterol (-2.3 [-3.8, -0.9], p < 0.002). There were no differences in total cholesterol or low-density lipoprotein-cholesterol or clinical differences in glycated hemoglobin.
For a given BMI, obesity treatment-seeking youth are more adversely affected by cardiometabolic risk factors than the general population of youth with obesity. This suggests that treatment-seeking youth may represent a distinct group that is at particularly high risk for the development of future cardiometabolic disease.
尽管肥胖影响着约五分之一的青少年,但只有一小部分在儿科体重管理诊所接受治疗。寻求体重管理治疗的肥胖青少年与未寻求治疗的肥胖青少年之间的区别特征在很大程度上尚不清楚。然而,识别区分寻求治疗与未寻求治疗的肥胖青少年的特定健康特征,可能有助于揭示寻求治疗的潜在动机。
在控制体重指数(BMI)的同时,比较寻求肥胖治疗的青少年样本与基于人群的肥胖青少年样本的心脏代谢特征。
这项横断面研究纳入了年龄在12 - 17岁的肥胖参与者,分别来自儿科肥胖与体重评估登记处(POWER)和国家健康与营养检查调查,分别代表寻求治疗的样本和人群样本。计算收缩压和舒张压百分位数、总胆固醇、低密度和高密度脂蛋白胆固醇、甘油三酯、空腹血糖、糖化血红蛋白和丙氨酸氨基转移酶的平均差异,同时调整年龄、性别、种族/族裔、保险状况以及第95百分位BMI的倍数。
POWER队列和国家健康与营养检查调查队列分别包括1823名和617名参与者。POWER队列的收缩压百分位数更高(平均差异17.4,95%置信区间[14.6, 20.1],p < 0.001),舒张压百分位数更高(21.8 [19, 24.5],p < 0.001),甘油三酯更高(42.3 [28, 56.5],p < 0.001),丙氨酸氨基转移酶更高(7.5 [5.1, 9.8],p < 0.001),而空腹血糖更低(-6.9 [-8.2, -5.6],p < 0.001),高密度脂蛋白胆固醇更低(-2.3 [-3.8, -0.9],p < 0.002)。总胆固醇或低密度脂蛋白胆固醇以及糖化血红蛋白的临床差异无统计学意义。
对于给定的BMI,寻求肥胖治疗的青少年比一般肥胖青少年人群更容易受到心脏代谢危险因素的不利影响。这表明寻求治疗的青少年可能代表一个独特的群体,未来患心脏代谢疾病的风险特别高。